Vaxcyte
PCVX
PCVX
197 hedge funds and large institutions have $5B invested in Vaxcyte in 2023 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 106 increasing their positions, 39 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
+10
Holders Change %
+5.35%
% of All Funds
3.11%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.17%
New
37
Increased
106
Reduced
39
Closed
25
Calls
$6.1M
Puts
$24.7M
Net Calls
-$18.6M
Net Calls Change
-$22M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$702M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$109M |
| 3 |
BlackRock
New York
|
$353M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
$94.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$411M |
